Sutro Biopharma, Inc.
STRO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $66 | $64 | $106 | $190 |
| Short-Term Investments | $102 | $141 | $143 | $127 |
| Receivables | $4 | $8 | $14 | $9 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $11 | $19 | $25 | $18 |
| Total Curr. Assets | $182 | $232 | $287 | $343 |
| Property Plant & Equip (Net) | $27 | $30 | $33 | $36 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $1 | $8 |
| Total NC Assets | $28 | $31 | $34 | $44 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $210 | $262 | $321 | $387 |
| Liabilities | – | – | – | – |
| Payables | $7 | $4 | $8 | $10 |
| Short-Term Debt | $8 | $8 | $8 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $9 | $12 | $69 | $70 |
| Other Curr. Liab. | $48 | $50 | $48 | $44 |
| Total Curr. Liab. | $72 | $74 | $133 | $132 |
| LT Debt | $10 | $212 | $14 | $16 |
| Deferred Rev, NC | $0 | $7 | $199 | $193 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $215 | $2 | $2 | $2 |
| Total NC Liab. | $225 | $220 | $214 | $211 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $20 | $21 | $23 |
| Total Liabilities | $297 | $294 | $347 | $343 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$931 | -$874 | -$863 | -$787 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $844 | $842 | $837 | $831 |
| Total Equity | -$87 | -$32 | -$26 | $45 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $210 | $262 | $321 | $387 |
| Net Debt | -$48 | $156 | -$85 | -$167 |